Work With Your Doctor to Get Lutathera (Lutetium Lu-177 Dotatate) Approved by Blue Cross Blue Shield in New Jersey
Getting Lutathera Covered: Your Path to Approval
Lutathera (lutetium Lu-177 dotatate) requires prior authorization from Blue Cross Blue Shield in New Jersey. Success depends on documenting somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs), progression on first-line somatostatin analog therapy, and meeting specific medical necessity criteria. The fastest path: work closely with